Approval · Notice of Compliance 18329 · 2016
DRONTAL PLUS: Notice of Compliance 18329
Issued August 4, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18329
- Date
- August 4, 2016
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DRONTAL PLUS | 02169517 | Marketed |
| DRONTAL PLUS | 02169525 | Marketed |
Medicinal ingredients
- FEBANTEL 113.4 MG per TAB
- PRAZIQUANTEL 22.7 MG per TAB
- PYRANTEL PAMOATE 22.7 MG per TAB
- FEBANTEL 340.2 MG per TAB
- PRAZIQUANTEL 68 MG per TAB
- PYRANTEL PAMOATE 68 MG per TAB